Decitabine and Vaccine Therapy for Patients With Relapsed AML Following Allogeneic Stem Cell Transplantation
This study is currently recruiting participants.
Verified November 2011 by Penn State University
Sponsor:
Penn State University
Information provided by (Responsible Party):
Kenneth G. Lucas, Penn State University
ClinicalTrials.gov Identifier:
NCT01483274
First received: November 3, 2011
Last updated: November 30, 2011
Last verified: November 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | March 2016 |
| Estimated Primary Completion Date: | December 2015 (Final data collection date for primary outcome measure) |